Actos Bladder Cancer Class Action Lawsuit Filed Abroad

Share Article

Individuals who developed Actos bladder cancer have filed an Actos class action lawsuit in Quebec, alleging that the drug makers were responsible for failure to warn about Actos side effects.

Bernstein Liebhard LLP | Consumer Injury Lawyers
The complaint was filed by lead plaintiff Jimmy Whyte, who took Actos to treat his type-2 diabetes in November 2008, and developed bladder cancer in April 2012.

An Actos class action lawsuit was filed in Quebec on behalf of individuals in the province who developed bladder cancer after using Actos, Bernstein Liebhard LLP reports.* The lawsuit alleges that Actos manufacturers Takeda Pharmaceuticals and Eli Lilly were responsible for failing to warn consumers about the risks of Actos bladder cancer. The complaint was filed by lead plaintiff Jimmy Whyte, who took Actos to treat his type-2 diabetes in November 2008, and developed bladder cancer in April 2012. Actos is a popular diabetic drug that has been linked to an increased risk of bladder cancer. In June 2011, the U.S. Food and Drug Administration added a warning label for Actos, advising consumers that using the drug for longer than a year may increase the risk of developing bladder cancer. Health regulators in France removed Actos from the market, essentially issuing an Actos recall, in June 2011 after identifying the increased incidences of bladder cancer in Actos users.

Actos Bladder Cancer Lawsuits Proceeds In U.S.

Claims in the Actos bladder cancer class action lawsuit are similar to the complaints filed in the U.S. Actos bladder cancer lawsuits. Actos lawsuits in the U.S. are part of a multidistrict litigation, referred to as an MDL. Unlike a class action lawsuit, in an MDL, each claim remains an individual lawsuit. However, the court coordinates proceedings such as pre-trial discovery. Plaintiffs in the Actos lawsuits allege that the drug caused them to develop bladder cancer. Bernstein Liebhard LLP, a nationwide law firm representing clients who have been injured by dangerous drugs and defective medical devices, is currently evaluating and investigating potential Actos claims.

Actos bladder cancer lawsuits are moving towards trial in the federal action, In re: Actos (Pioglitazone) Products Liability Litigation (“MDL No. 2299”), currently pending before the Honorable Rebecca Doherty in the U.S. District Court for the Western District of Louisiana.

Those who developed bladder cancer as a result of taking Actos may be able to collect compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about Actos bladder cancer lawsuits by visiting our website, Contact a lawyer at Bernstein Liebhard LLP for a free case review (877) 779-1414.


About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website